Novavax, Inc Equity-NMS: NVAX

Healthcare

Biotechnology

Buy/Sell an entire stock
or a fraction.
Powered by Vested Vested

Already an existing customer?

New User?

Open Your Free Demat Account And Start Trading Seamlessly
Loading, Please wait...
Previous close :$5.98
Open :$5.58
Today's high :$5.83
Today's low :$5.35
52W low :$3.81
52W high :$23.8599
EPS(TTM): :-1.23
Shares O/S :160.84 M
Market cap :900.73 M

Compare with Other Stocks

Stocks Price 1D PE Market Cap
Novavax, Inc $5.6 +0% - 900.73M

Frequently Asked Questions

What is the share price of Novavax, Inc today?

Novavax, Inc (NVAX) share price as of January 1, 1970, is $. If you are investing from India, you can always check the valuation in the INR before investing.

About Novavax, Inc

Novavax, Inc. is a biotechnology company, which discovers, develops and commercializes vaccines to prevent serious infectious diseases. The Company offers a differentiated vaccine platform that combines a recombinant protein approach, advanced nanoparticle technology and its patented Matrix-M adjuvant to enhance the immune response. It has one commercial program, for vaccines to prevent COVID-19, which includes Nuvaxovid prototype COVID-19 vaccine (NVX-CoV2373 or prototype vaccine) and Nuvaxovid updated COVID-19 vaccine (NVX-CoV2601 or updated vaccine) (collectively, COVID-19 Vaccine). The Company is advancing the development of other vaccine candidates, including its COVID19-Influenza Combination (CIC) vaccine candidate and additional vaccine candidates. Its COVID-19 Vaccine and its other vaccine candidates incorporate the Company’s proprietary Matrix-M adjuvant to enhance the immune response and stimulate higher levels of functional antibodies and induce a cellular immune response.